Ibnsina Pharma results, Fiscal year 2021
Net profit, assets, equity and cash flow for Fiscal year 2021, against the same period a year earlier, from the published financial statements.
Net profit315 millionEGP
Total assets11.28 billionEGP
Shareholders' equity1.45 billionEGP
Operating cash flow-340 millionEGP
In short
- Ibnsina Pharma's net profit for Fiscal year 2021 was about 315 million EGP.
- Total assets at the end of Fiscal year 2021 were about 11.28 billion EGP, and shareholders' equity about 1.45 billion EGP.
- Operating cash flow for Fiscal year 2021 was negative at 340 million EGP.
Key lines against the same period a year earlier
This periodYear earlierChange
Net profit315 million——
Gross profit1.63 billion——
Total assets11.28 billion——
Total liabilities9.83 billion——
Shareholders' equity1.45 billion——
Total liabilities and equity11.28 billion——
Operating cash flow-340 million——
Investing cash flow-143 million——
Financing cash flow681 million——
Net change in cash198 million——
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.
Ibnsina Pharma's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy